Getsinger Peter W 4
4 · ARGAN INC · Filed Jun 17, 2026
Research Summary
AI-generated summary of this filing
Argan (AGX) Director Peter Getsinger Exercises Options, Sells Shares
What Happened
Peter W. Getsinger, a director of Argan, Inc. (AGX), exercised stock options and promptly sold shares. On June 15, 2026 he exercised an option awarded Dec 16, 2022 to purchase 5,000 shares at $35.72 each (net-settle). As reported, 4,728 shares were acquired at $35.72 (cost ~$168,884) and then 4,728 shares were sold on June 16, 2026 for an average of $708.65 ($3,350,497). He also sold 2,000 additional shares on June 17, 2026 at an average of $699.00 ($1,398,000). Total open-market proceeds reported: ~$4.75 million.
Key Details
- Transaction dates and prices:
- 2026-06-15: Exercised option to purchase 5,000 shares at $35.72 (net-settle) — exercise cost ~$178,600 (footnote F1).
- 2026-06-15: 4,728 shares reported acquired at $35.72 — $168,884 (transaction code M, footnote F1).
- 2026-06-16: Sold 4,728 shares at an average $708.65 — proceeds ~$3,350,497 (footnote F2).
- 2026-06-17: Sold 2,000 shares at an average $699.00 — proceeds $1,398,000 (footnote F3).
- Shares owned after the transactions: not specified in the provided filing.
- Notable footnotes: F1 confirms the June 15 exercise used the net-settle method (common for covering exercise cost/withholding). F2 and F3 describe the open-market sales on June 16–17.
- Filing timeliness: Report filed June 17, 2026 for a 6/15/2026 transaction — appears to have been filed within the typical 2-business-day Form 4 window.
Context
- This was an option exercise followed by immediate open-market sales (a common cashless/near-cashless pattern): options were exercised and shares were sold soon after. Such sales often reflect option liquidity or tax/exercise-related actions rather than a definitive view on the company’s outlook.
- The largest items here are sales (total proceeds ~ $4.75M); purchases consist of the option exercise at a low strike ($35.72) relative to the sale prices (~$699–708), producing substantial realized gain on the exercised shares.
Insider Transaction Report
Form 4
ARGAN INCAGX
Getsinger Peter W
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-06-15$35.72/sh+4,728$168,884→ 11,608 total - Sale
Common Stock
[F2]2026-06-16$708.65/sh−4,728$3,350,497→ 6,880 total - Sale
Common Stock
[F3]2026-06-17$699.00/sh−2,000$1,398,000→ 4,880 total - Exercise/Conversion
Option to Purchase Common Stock
[F1]2026-06-15$35.72/sh−5,000$178,600→ 3,000 totalExercise: $35.72From: 2023-12-16Exp: 2033-12-16→ Common Stock (5,000 underlying)
Holdings
- 267(indirect: By Trust)
Common Stock
- 133(indirect: By Children)
Common Stock
Footnotes (3)
- [F1]On June 15, 2026, the Reporting Person exercised his stock option awarded on December 16, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $35.72 per share using the net settle method.
- [F2]On June 16, 2026, the Reporting Person sold 4,728 shares of the Issuer's common stock on the open market at an average price of $708.65 per share.
- [F3]On June 17, 2026, the Reporting Person sold 2,000 shares of the Issuer's common stock on the open market at an average price of $699.00 per share.
Signature
/s/ Peter W. Getsinger|2026-06-17